This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The recent editorial by Paul Stein¹ raises some important points about the clinical significance of silent pulmonary embolism (PE). I believe that the answer to his question as to whether silent PE may result in death is already evident in the pathology literature. Pathologists have often observed that in many if not most cases, a fatal PE is the terminal event in a series of emboli that have not been recognized.² Pathologists have also noted for the last 40 years or more that most fatal embolisms are an unexpected postmortem finding (ie, clinically silent).³ Fatal PE occurs commonly in the setting of serious comorbidity, when it is often a terminal event. Many cases also occur among patients with dementia or aphasia who cannot give a history, and hence these are also "silent." In systematic screening studies of the type described by Meignan et al,⁴ silent PE has generally been 4 . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Silent Pulmonary Embolism
Paul D. Stein
Arch Intern Med. 2000;160(2):145-146.
EXTRACT | FULL TEXT  

Changing Clinical Practice: Prospective Study of the Impact of Continuing Medical Education and Quality Assurance Programs on Use of Prophylaxis for Venous Thromboembolism
Frederick A. Anderson, Jr, H. Brownell Wheeler, Robert J. Goldberg, David W. Hosmer, Ann Forcier, and Nilima A. Patwardhan
Arch Intern Med. 1994;154(6):669-677.
ABSTRACT